Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 5/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 4/20 | 0.32 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | DUT | P33316 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30018075 | 0.82 | DGAT1 (0.38) | DGAT1PDE10ANPC1HTR2AHTR2C | |
| SCHEMBL19204030 | 0.78 | DGAT1 (0.40) | DGAT1PDE10AKLKB1NPC1DUT | |
| SCHEMBL28840671 | 0.78 | HTR2C (0.48) | DGAT1PDE10ANPC1HTR2AHTR2C | |
| SCHEMBL29925168 | 0.78 | HTR2C (0.48) | DGAT1PDE10ANPC1HTR2AHTR2C | |
| SCHEMBL26728337 | 0.75 | HTR2A (0.48) | DGAT1PDE10AKLKB1HTR2AHTR2C | |
| SCHEMBL4503124 | 0.75 | ADRA2A (0.43) | DGAT1PDE10AKLKB1DUT | |
| SCHEMBL31358047 | 0.75 | DGAT1 (0.41) | DGAT1HTR2AHTR2C | |
| SCHEMBL16192744 | 0.75 | DGAT1 (0.37) | DGAT1HTR2AHTR2CDUT | |
| SCHEMBL22778051 | 0.74 | DGAT1 (0.36) | DGAT1NPC1HTR2AHTR2CDUT | |
| SCHEMBL29714404 | 0.74 | DGAT1 (0.36) | DGAT1NPC1HTR2AHTR2CDUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4573088-A1 | HETEROCYCLE RBM39 MODULATORS | Recursion Pharmaceuticals, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| WO-2024039689-A1 | HETEROCYCLE RBM39 MODULATORS | RECURSION PHARMACEUTICALS, INC. (US) | 2024-02-22 | — | — | WO | disclosed |